This week in the micro-cap trenches is a masterclass in the creative destruction of shareholder value. We have everything from C-suite executives trying to pull the ripcord on unearned golden parachutes, to legacy retail giants realizing TikTok won't save them from billions in debt. When the highlight of the week is a bank finding $40 million of bad loans in the couch cushions, you know it's business as usual at the bottom of the market.
BioRestorative Therapies (BRTX)
The Filing: CEO Lance Alstodt and CFO Robert Kristal abruptly resigned, claiming "Good Reason" due to a "Change in Control." They demanded $2.85 million in severance and accelerated equity vesting. To add to the chaos, a director resigned a few days prior.
Since Then: It turns out this isn't a tragic coincidence; it's a standoff. The board flatly rejected the executives' severance claims, stating no valid control change actually occurred. Just days prior on July 8, the board amended the employment agreements to dramatically tighten the definition of a "Change in Control". Now Katharyn Field is playing both interim CEO and CFO while the board fights its former C-suite for the cash. It is a textbook executive shootout over a golden parachute that the board explicitly intends to shoot down.
QVC Group, Inc. (QVCGA)
The Filing: QVC filed its monthly Chapter 11 operating report, confirming the bankruptcy court blessed its pre-packaged financial restructuring plan.
Since Then: The court approved a plan to slash debt from over $6 billion down to about $1.3 billion in takeback debt, meaning the common equity is functionally dead. Nasdaq didn't wait around, suspending and delisting both the common and the 8% preferred shares this week. QVCGA stock cratered 70% to around $0.53 and is now languishing on the OTC markets. The company blamed cord-cutting and claimed it was pivoting to live social shopping. As it turns out, selling Martha Stewart sweaters on TikTok isn't enough to service cable-era leverage.
Digital Brands Group, Inc. (DBGI)
The Filing: DBGI signed an agreement with the majority holder of its Series D Convertible Preferred Stock to reset the conversion "Floor Price." If you read SEC filings for fun, you know that resetting a floor price to a fraction of the current trading price is a euphemism for a death spiral.
Since Then: The very same day, DBGI announced a 1-for-40 reverse split effective July 24. They had to do it. The stock is sitting at $0.64 and down over 93% on the year. The reverse split shrinks the float from 23 million shares down to a microscopic 575,000 shares, explicitly to maintain Nasdaq compliance. They reset the toxic preferred conversion terms to print more equity, then reverse split the common so they can keep printing it on a major exchange. The dilution machine just needed a fresh coat of paint.
BayFirst Financial Corp. (BAFN)
The Filing: BayFirst is restating its financials for 2024, 2025, and Q1 2026. The bank identified material errors in provision expenses and net interest income, and warned of massive asset write-downs tied to an "asset resolution plan."
Since Then: The actual damage clocks in at $40.1 million in charges tied mostly to government-guaranteed SBA and USDA loans. Q1 2026 EPS is being restated to a $1.48 loss, and the board is now undertaking a clawback review of executive compensation. Oddly enough, the market saw this balance sheet clearing coming. BAFN brought in new capital back in April via a stock purchase agreement, and despite being down 62% over the past year, the stock actually bounced over 12% this month. Investors are treating the $40 million write-down as the final clearing event before the bank can start fresh.
Caring Brands, Inc. (CABR)
The Filing: Nasdaq handed CABR a delisting notice for holding a mere $2.09 million in stockholders' equity, missing the $2.5 million minimum requirement. The company is appealing the decision to delay the impending July 24 trading suspension.
Since Then: To plug the equity hole, Caring Brands scrambled to execute a $400,000 PIPE deal on July 17, issuing 443 Series A preferred shares alongside warrants exercisable at $0.40. Prior to that, they held a special meeting to increase authorized common shares from 100 million to 500 million. They are frantically stuffing the balance sheet with highly dilutive preferred equity just to prove to the Nasdaq hearings panel that they deserve to stay listed. The stock is floating around $1.30, but the capital structure is being gutted from the inside out to buy time.
What to Watch: Keep an eye on DBGI's post-split price action next week. These low-float reverse splits often create brief, violent volatility before gravity and the newly minted preferred conversions take hold. Meanwhile, the BRTX boardroom brawl is heading for a messy legal resolution. We will see if the former executives get their $2.85 million, or if the board's preemptive contract rewrite holds up in court.